F. De Rose
Humanitas University
11 Papers
18 Citations
F. De Rose is an academic researcher from Humanitas University. The author has contributed to research in topics: Radiation therapy & Lung cancer. The author has an hindex of 7, co-authored 11 publications.
Chat about Author
Papers
Clinical Outcome of Stereotactic Ablative Body Radiotherapy for Lung Metastatic Lesions in Non-small Cell Lung Cancer Oligometastatic Patients
F. De Rose,Luca Cozzi,Piera Navarria,A.M. Ascolese,Elena Clerici,Maurizio Infante,Marco Alloisio,Alberto Testori,Luca Toschi,Giovanna Finocchiaro,Armando Santoro,Marta Scorsetti +11 more
TL;DR: SABR is well tolerated with a good radiological response and toxicity profile, and Discussion within a multidisciplinary team is crucial to identify the oligometastatic patients who would probably benefit from ablative local therapy.
51
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low-Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients.
Giuseppe D'Agostino,C. Franzese,F. De Rose,Davide Franceschini,Tiziana Comito,Elisa Villa,Filippo Alongi,R.L.E. Liardo,Stefano Tomatis,Piera Navarria,P. Mancosu,Giacomo Reggiori,L. Cozzi,Marta Scorsetti +13 more
TL;DR: Stereotactic body radiotherapy delivered using linac-based flattening filter free volumetric modulated arc radiotherapy in low and intermediate risk prostate cancer patients is associated with mild toxicity profiles and good patient-reported quality of life.
37
Organs at risk in lung SBRT.
F. De Rose,Davide Franceschini,Giacomo Reggiori,Antonella Stravato,Piera Navarria,A.M. Ascolese,Stefano Tomatis,P. Mancosu,Marta Scorsetti +8 more
TL;DR: A non-systematic review of dose constraints for lung SBRT was performed, including the main organs at risk in the thorax, and dose-adapted fractionation schedules and ongoing prospective trials should provide further evidence of S BRT safety trying to reduce toxicities and complications.
28
Radical hypo-fractionated radiotherapy with volumetric modulated arc therapy in lung cancer
Davide Franceschini,F. De Rose,Luca Cozzi,Piera Navarria,Elena Clerici,C. Franzese,Tiziana Comito,Angelo Tozzi,Cristina Iftode,Giuseppe D'Agostino,M. Sorsetti +10 more
TL;DR: In this article, the feasibility and acute toxicity of radical hypo-fractionated radiotherapy (RT) for elderly patients with non-small-cell lung cancer (NSCLC) were analyzed.
8